Anti-β2-glycoprotein I in Sjogren's syndrome is associated with parkinsonism

Clinical Rheumatology

Volumn 26, Issue 5, 2007, Pages 743-747

  Hassin Baer, Sharon ^a   Levy, Yair ^a   Langevitz, Pnina ^a   Nakar, Sasson ^a   Ehrenfeld, Michael ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti 2 glycoprotein glycoprotein I; Anticardiolipin; Parkinson's disease; Parkinsonism; Sjogren's syndrome

Indexed keywords

AMANTADINE; AMITRIPTYLINE; ARTIFICIAL TEAR; AUTOANTIBODY; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; CLONAZEPAM; IMMUNOGLOBULIN G; LEVODOPA; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; PERGOLIDE; PILOCARPINE; ROPINIROLE; SELEGILINE; SULPIRIDE; BETA2 GLYCOPROTEIN 1;

ADULT; AGED; ANTIBODY TITER; ANTIPHOSPHOLIPID SYNDROME; ARTHRALGIA; ARTICLE; BASAL GANGLION; CASE REPORT; DEPRESSION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FATIGUE; FEMALE; FIBROMYALGIA; HUMAN; LOW DRUG DOSE; MALE; NAUSEA; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; SJOEGREN SYNDROME; THROMBOEMBOLISM; XEROPHTHALMIA; BLOOD; FOLLOW UP; IMMUNOLOGY; MIDDLE AGED; PARKINSON DISEASE;

AGED; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PARKINSON DISEASE; SJOGREN'S SYNDROME;

EID: 34147113400     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0398-8     Document Type: Article

References (26)

1. Alexander E (1992) Central nervous system disease in Sjogren's syndrome. New insights into immunopathogenesis. Rheum Dis Clin North Am 18(3):637-672
2. Nishimura H, Tachibana H, Makiura N, Okuda B, Sugita M (1994) Corticosteroid-responsive parkinsonism associated with primary Sjogren's syndrome. Clin Neurol Neurosurg 96(4):327-331
3. Creange A, Sedel F, Brugieres P, Voisin MC, Degos JD (1997) Primary Sjogren's syndrome presenting as progressive parkinsonian syndrome. Mov Disord 12(1):121-123
4. Fabre N, Faucheux J, Roland Y, Cantagrel A, Geraud G (1996) Corticosteroid-responsive parkinsonism associated with primary Sjogren's syndrome: Report of two cases (abstract). Neurology 46:A299
5. Hashimoto S, Sawada T, Inoue T, Yamamoto K, Iwata M (1999) Cholinergic-drug induced sicca syndrome in Parkinson's disease: A case report and a review of the literature. Clin Neurol Neurosurg 101(4):268-270
6. Miyoshi Y, Atsumi T, Kitagawa H, Ogura N, Amasaki Y, Tsutsumi A et al (1993) Parkinson-like symptoms as a manifestation of systemic lupus erythematosus. Lupus 2(3):199-201
7. Walker RH, Spiera H, Brin MF, Olanow CW (1999) Parkinsonism associated with Sjogren's syndrome: Three cases and a review of the literature. Mov Disord 14(2):262-268
8. Visser LH, Koudstaal PJ, van de Merwe JP (1993) Hemiparkinsonism in a patient with primary Sjogren's syndrome. A case report and a review of the literature. Clin Neurol Neurosurg 95(2):141-145
9. Vitali C, Bombardieri S, Moutsopoulos HM, Coll J, Gerli R, Hatron PY et al (1996) Assessment of the European classification criteria for Sjogren's syndrome in a series of clinically defined cases: Results of a prospective multicenter study. The European Study Group on Diagnostic Criteria for Sjogren's Syndrome. Ann Rheum Dis 55(2):116-121
10. Alexander EL (1993) Neurologic disease in Sjogren's syndrome: mononuclear inflammatory vasculopathy affecting central/peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am 19(4):869-908
11. Greco TP, Amos MD, Conti-Kelly AM, Naranjo JD, Ijdo JW (2000) Testing for the antiphospholipid syndrome: Importance of IgA anti-beta 2-glycoprotein I. Lupus 9(1):33-41
12. Osawa H, Yamabe H, Kaizuka M, Tamura N, Tsunoda S, Shirato KI et al (1997) Systemic lupus erythematosus associated with transverse myelitis and parkinsonian symptoms. Lupus 6(7):613-615
13. Mochizuki H, Okano M, Masaki T, Nagata N, Kamakura K (1997) A case of Sjogren's syndrome with a high titer of anticardiolipin antibody that developed as parkinsonism. Rinsho Shinkeigaku 37(1):57-59
14. Shahar E, Goshen E, Tauber Z, Lahat E (1998) Parkinsonian syndrome complicating systemic lupus erythematosus. Pediatr Neurol 18(5):456-458
15. Inanc M, Donohoe S, Ravirajan CT, Radway-Bright EL, Mackie I, Machin S et al (1998) Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol 37(10):1089-1094
16. Merkel PA, Chang Y, Pierangeli SS, Convery K, Harris EN, Polisson RP (1996) The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 101(6):576-583
17. Pennec YL, Magadur G, Jouquan J, Youinou P (1991) Serial measurements of anticardiolipin antibodies in primary Sjogren's syndrome. Clin Exp Rheumatol 9(2):165-167
18. Cervera R, Garcia-Carrasco M, Font J, Ramos M, Reverter JC, Munoz FJ et al (1997) Antiphospholipid antibodies in primary Sjogren's syndrome: prevalence and clinical significance in a series of 80 patients. Clin Exp Rheumatol 15(4):361-365
19. Jedryka-Goral A, Jagiello P, D'Cruz DP, Maldykowa H, Khamashta MA, Hughes GR et al (1992) Isotype profile and clinical relevance of anticardiolipin antibodies in Sjogren's syndrome. Ann Rheum Dis 51(7):889-891
20. Verrotti A, Cieri F, Pelliccia P, Morgese G, Chiarelli F (2000) Lack of association between antiphospholipid antibodies and migraine in children. Int J Clin Lab Res 30(2):109-111
21. Tietjen GE, Day M, Norris L, Aurora S, Halvorsen A, Schultz LR et al (1998) Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: A prospective study. Neurology 50(5):1433-1440
22. Pal B, Gibson C, Passmore J, Griffiths ID, Dick WC (1989) A study of headaches and migraine in Sjogren's syndrome and other rheumatic disorders. Ann Rheum Dis 48(4):312-316
23. Caronti B, Calderaro C, Alessandri C, Conti F, Tinghino R, Pini C et al (1998) Serum anti-beta2-glycoprotein I antibodies from patients with antiphospholipid antibody syndrome bind central nervous system cells. J Autoimmun 11(5):425-429
24. Brunella C, Valerio P, Guido P, Guido V (1998) Anti-b-glycoprotein I antibodies bind to central nervous system. J Neurol Sci 156:211-219
25. Shoenfeld Y, Nahum A, Korczyn AD, Dano M, Rabinowitz R, Beilin O, Pick CG, Leider-Trejo L, Kalashnikova L, Blank M, Chapman J (2003) Neuronal-binding antibodies from patients with antiphospholipid syndrome induce cognitive deficits following intrathecal passive transfer. Lupus 12:436-442
26. Shrot S, Katzav A, Korczyn AD, Litvinjuk Y, Hershenson R, Pick CG, Blank M, Zaech J, Shoenfeld Y, Sirota P, Chapman J (2002) Behavioral and cognitive deficits occur only after prolonged exposure of mice to antiphospholipid antibodies. Lupus 11:736-743